NYSE - Delayed Quote USD

Cencora, Inc. (COR)

290.22
+4.80
+(1.68%)
At close: May 16 at 4:00:02 PM EDT
288.51
-1.71
(-0.59%)
After hours: May 16 at 7:27:35 PM EDT
Loading Chart for COR
  • Previous Close 285.42
  • Open 285.76
  • Bid 289.81 x 900
  • Ask 290.30 x 1200
  • Day's Range 285.55 - 290.52
  • 52 Week Range 214.77 - 309.35
  • Volume 1,355,470
  • Avg. Volume 1,870,525
  • Market Cap (intraday) 56.251B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 33.55
  • EPS (TTM) 8.65
  • Earnings Date Jul 29, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 2.20 (0.76%)
  • Ex-Dividend Date May 16, 2025
  • 1y Target Est 317.09

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

www.cencora.com

42,000

Full Time Employees

September 30

Fiscal Year Ends

Recent News: COR

View More

Performance Overview: COR

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COR
29.71%
S&P 500 (^GSPC)
1.30%

1-Year Return

COR
31.95%
S&P 500 (^GSPC)
12.48%

3-Year Return

COR
93.57%
S&P 500 (^GSPC)
48.66%

5-Year Return

COR
259.40%
S&P 500 (^GSPC)
108.07%

Compare To: COR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COR

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    56.22B

  • Enterprise Value

    62.10B

  • Trailing P/E

    33.59

  • Forward P/E

    18.80

  • PEG Ratio (5yr expected)

    0.90

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    55.51

  • Enterprise Value/Revenue

    0.20

  • Enterprise Value/EBITDA

    16.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.55%

  • Return on Assets (ttm)

    2.97%

  • Return on Equity (ttm)

    141.78%

  • Revenue (ttm)

    310.23B

  • Net Income Avi to Common (ttm)

    1.69B

  • Diluted EPS (ttm)

    8.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.98B

  • Total Debt/Equity (mrq)

    827.73%

  • Levered Free Cash Flow (ttm)

    3.88B

Research Analysis: COR

View More

Company Insights: COR

Research Reports: COR

View More

People Also Watch